{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:33:37Z","timestamp":1781742817667,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacl.2024.03.009","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T16:47:41Z","timestamp":1711730861000},"page":"e537-e547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia"],"prefix":"10.1016","volume":"18","author":[{"given":"Katarina","family":"Raslova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viera","family":"Donicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0503-7973","authenticated-orcid":false,"given":"Katarina","family":"Gonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Klabnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-0621","authenticated-orcid":false,"given":"Lukas","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Buckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zachlederova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7053","authenticated-orcid":false,"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6400-2200","authenticated-orcid":false,"given":"Branislav","family":"Vohnout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.03.009_bib0001","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0002","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/heartjnl-2017-312706","article-title":"Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia","volume":"104","author":"Mundal","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2024.03.009_bib0003","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.03.009_bib0004","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0005","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.03.009_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0969141318796856","article-title":"Integration of child-parent screening and cascade testing for familial hypercholesterolaemia","volume":"26","author":"Wald","year":"2019","journal-title":"J Med Screen"},{"key":"10.1016\/j.jacl.2024.03.009_bib0007","first-page":"2103","article-title":"Universal screening for familial hypercholesterolemia in 2 populations","volume":"24","author":"Sustar","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.jacl.2024.03.009_bib0008","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0009","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","article-title":"Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations","volume":"29","author":"Gidding","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacl.2022.03.002","article-title":"Phenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populations","volume":"16","author":"Fourgeaud","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0011","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2015.06.1340","article-title":"Lipid screening in children","volume":"66","author":"Daniels","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0012","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klan\u010dar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0013","first-page":"S34","article-title":"[Primary prevention of atherosclerosis in childhood]","volume":"3","author":"\u0160imurka","year":"2003","journal-title":"Intern\u00e1 medic\u00edna"},{"key":"10.1016\/j.jacl.2024.03.009_bib0014","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2016.9852","article-title":"Screening for lipid disorders in children and adolescents: US preventive services task force recommendation statement","volume":"316","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jacl.2024.03.009_bib0015","unstructured":"World Health Organization Human Genetics Programme. Familial hypercholesterolaemia (FH): report of a second WHO consultation, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/66346\/WHO_HGN_FH_CONS_99.2.pdf?sequence=1&isAllowed=y, (1999, accessed 18 January 2024)."},{"key":"10.1016\/j.jacl.2024.03.009_bib0016","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.03.009_bib0017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2018.06.857","article-title":"Treatment pattern of familial hypercholesterolemia in Slovakia:tTargets, treatment and obstacles in common practice","volume":"277","author":"Vohnout","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.03.009_bib0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.33549\/physiolres.933348","article-title":"The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey","volume":"66","author":"Gab\u010dov\u00e1","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.jacl.2024.03.009_bib0019","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/eurheartj\/ehl113","article-title":"Diagnosing familial hypercholesterolaemia: the relevance of genetic testing","volume":"27","author":"van Aalst-Cohen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0020","unstructured":"Slovak National Health Information Center. [Preventive care in the Slovak Republic 2020], https:\/\/www.nczisk.sk\/Aktuality\/Pages\/Preventivna-starostlivost-v-Slovenskej-republike-2020.aspx (2020, accessed 28 November 2023)."},{"key":"10.1016\/j.jacl.2024.03.009_bib0021","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.08.002","article-title":"National lipid association annual summary of clinical lipidology 2016","volume":"10","author":"Bays","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0022","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2017.07.001","article-title":"Familial hypercholesterolemia: the Italian Atherosclerosis Society Network (LIPIGEN)","volume":"29","author":"Averna","year":"2017","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2024.03.009_bib0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-015-0037-z","article-title":"Familial hypercholesterolemia: a review of the natural history, diagnosis, and management","volume":"4","author":"Najam","year":"2015","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.jacl.2024.03.009_bib0024","first-page":"293","article-title":"The clinical genome resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Gen Med"},{"key":"10.1016\/j.jacl.2024.03.009_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2024.03.009_bib0026","article-title":"The time is now: achieving FH paediatric screening across Europe - the Prague Declaration","volume":"16","author":"Bedlington","year":"2022","journal-title":"GMS health innovation and technologies"},{"key":"10.1016\/j.jacl.2024.03.009_bib0027","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0028","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101142","article-title":"Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management","volume":"5","author":"M\u00fclverstedt","year":"2021","journal-title":"BJGP open"},{"key":"10.1016\/j.jacl.2024.03.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa122","article-title":"Management of familial hypercholesterolemia: current status and future perspectives","volume":"5","author":"Lui","year":"2021","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/j.jacl.2024.03.009_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0031","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.03.009_bib0032","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.jacl.2024.03.009_bib0033","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1186\/s12889-019-7901-z","article-title":"Scheidt-Nave C. Age, maturation and serum lipid parameters: findings from the German health survey for children and adolescents","volume":"19","author":"Schienkiewitz","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacl.2024.03.009_bib0034","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MOL.0b013e3283556c33","article-title":"Identification of people with heterozygous familial hypercholesterolemia","volume":"23","author":"Haase","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0035","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2015.08.871","article-title":"Characterization of the first PCSK9 gain of function homozygote","volume":"66","author":"Alves","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.03.009_bib0036","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/cge.13832","article-title":"Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia","volume":"98","author":"Marmontel","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2024.03.009_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/genes12010066","article-title":"The LDLR, APOB, and PCSK9 variants of index patients with familial hypercholesterolemia in Russia","volume":"12","author":"Meshkov","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jacl.2024.03.009_bib0038","article-title":"Low detection rates of genetic FH in cohort of patients with severe hypercholesterolemia in the united Arabic emirates","volume":"12","author":"Rimbert","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jacl.2024.03.009_bib0039","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1038\/s41467-019-11526-w","article-title":"Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution","volume":"10","author":"Kircher","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2024.03.009_bib0040","doi-asserted-by":"crossref","first-page":"18184","DOI":"10.1038\/srep18184","article-title":"Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing familial hypercholesterolaemia provides novel insights into variant pathogenicity","volume":"5","author":"Fern\u00e1ndez-Higuero","year":"2015","journal-title":"Sci Rep"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T23:49:06Z","timestamp":1724975346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742400045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S193328742400045X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.03.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}